Viking Therapeutics aims to enter the billion-dollar weight loss drug market. The company is studying a candidate in a phase 3 trial. The weight loss drug market has been one key focus for investors ...

The Minnesota Vikings have announced the death of former cornerback Ronyell Whitaker at the age of 46. Whitaker's death on Sunday was confirmed by his family, who shared a statement paying tribute to ...

Minnesota Vikings defensive lineman Jalen Redmond lines up against the Los Angeles Rams during the NFC wild card playoff game on Jan. 13, 2025, at State Farm Stadium, preparing for a high-stakes ...

Archaeology undergraduates from the University of Cambridge were on a training dig when they discovered a group burial just three miles outside of town. Dated to the ninth century C.E., a time when ...

Gear-obsessed editors choose every product we review. We may earn commission if you buy from a link. Why Trust Us? Here’s what you’ll learn when you read this story: Archaeology undergraduates from ...

If the 2025 NFL season proved anything, it's that we should probably be more gracious with quarterbacks. Unfortunately, this is a grace that the Minnesota Vikings might not extend to second-year ...

The Minnesota Vikings are heading into the 2026 offseason with significant uncertainty at the quarterback position. After drafting J.J. McCarthy 10th overall in 2024, the team opted to move on from a ...

The QB situation for the Minnesota Vikings is one of the biggest storylines in the NFL this offseason. All eyes sit upon the job currently held by J.J. McCarthy, with the possibility of Minnesota ...

The Minnesota Vikings are in a complete cap crunch to begin the 2026 offseason. They currently sit roughly around -$40 million in cap space for the coming year. There is no need to panic, though.

Shares of Viking Therapeutics (VKTX) continued to rise in the premarket on Thursday after the company provided encouraging updates on its experimental obesity therapy, VK2735, with its Q4 2025 results ...

Lian indicated the oral VK2735 program is expected to advance into Phase III for obesity, with initiation targeted for the third quarter of 2026. "We currently expect to initiate this program in the ...

Feb 11 (Reuters) - Viking Therapeutics (VKTX.O), opens new tab said on Wednesday it plans to test its experimental oral obesity drug in a late-stage study later this year. Shares of the company rose ...